Is synergism between carnosic acid and arsenic trioxide on induction of acute myeloid leukemia cell apoptosis associated with modulation of PTEN/Akt signaling pathway?
CA might be a novel candidate of the combination therapy for leukemia treatment; these effects were apparently associated with the modulation of PTEN/Akt signaling pathway.
E2F1 may be a potential prognostic and predictive factor for clinical outcome and therapeutic results following adjuvant chemotherapy in HRNBC patients.